|
DDX60 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.483880E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.618500E-04 |
| Normal-vs-Stage2 |
8.376400E-01 |
| Normal-vs-Stage3 |
3.518000E-02 |
| Normal-vs-Stage4 |
5.066200E-02 |
| Stage1-vs-Stage2 |
1.998050E-02 |
| Stage1-vs-Stage3 |
4.215000E-01 |
| Stage1-vs-Stage4 |
7.719200E-01 |
| Stage2-vs-Stage3 |
9.297600E-02 |
| Stage2-vs-Stage4 |
8.990300E-02 |
| Stage3-vs-Stage4 |
7.624000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.977100E-04 |
| Normal-vs-AfricanAmerican |
2.119800E-02 |
| Normal-vs-Asian |
6.144100E-03 |
| Caucasian-vs-AfricanAmerican |
1.666240E-01 |
| Caucasian-vs-Asian |
6.308800E-01 |
| AfricanAmerican-vs-Asian |
4.146600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.035960E-01 |
| Normal-vs-Female |
6.994500E-04 |
| Male-vs-Female |
2.008800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.4496000000045E-05 |
| Normal-vs-Age(41-60Yrs) |
1.633610E-02 |
| Normal-vs-Age(61-80Yrs) |
4.787400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.312200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.723800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.556200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.581300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.801840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.701800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.714600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.562200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
5.098500E-02 |
| Classical-VS-Normal |
4.405300000343E-07 |
| Tall-VS-Follicular |
6.03959999999626E-05 |
| Tall-VS-Other |
6.087700E-02 |
| Tall-VS-Normal |
1.809920E-02 |
| Follicular-VS-Other |
6.367600E-01 |
| Follicular-VS-Normal |
8.215200E-04 |
| Other-VS-Normal |
2.594600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.729010E-01 |
| Normal-vs-N1 |
2.478300E-02 |
| N0-vs-N1 |
1.152560E-01 |
|
|
